Glenmede Trust’s Colgate-Palmolive CL Stock Holding History

Glenmede Trust’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$50.7M	Sell	595,265 -46,946	-7%	-$4.18M	0.25%	75
2025 Q4	$50.7M	Buy	+642,211	New	+$50.4M	0.24%	82
2025 Q1	$39.9M	Sell	425,357 -67,197	-14%	-$6.02M	0.21%	101
2024 Q4	$44.8M	Sell	492,554 -73,277	-13%	-$6.99M	0.23%	95
2024 Q3	$58.7M	Sell	565,831 -6,500	-1%	-$662K	0.28%	82
2024 Q2	$55.5M	Buy	572,331 +45,672	+9%	+$4.21M	0.28%	83
2024 Q1	$47.4M	Sell	526,659 -7,316	-1%	-$620K	0.24%	96
2023 Q4	$42.6M	Sell	533,975 -179,150	-25%	-$13.5M	0.22%	104
2023 Q3	$50.7M	Sell	713,125 -184,798	-21%	-$13.8M	0.29%	88
2023 Q2	$67.5M	Hold	897,923	–	–	0.38%	70
2023 Q1	$67.5M	Buy	897,923 +156,536	+21%	+$11.6M	0.38%	70
2022 Q4	$58.4M	Sell	741,387 -1,693	-0.2%	-$127K	0.34%	80
2022 Q3	$52.2M	Sell	743,080 -19,389	-3%	-$1.52M	0.33%	83
2022 Q2	$61.1M	Sell	762,469 -179,800	-19%	-$14.1M	0.36%	74
2022 Q1	$71.5M	Sell	942,269 -18,462	-2%	-$1.46M	0.35%	72
2021 Q4	$82M	Sell	960,731 -267,254	-22%	-$20.9M	0.39%	59
2021 Q3	$92.8M	Sell	1,227,985 -93,281	-7%	-$7.41M	0.48%	45
2021 Q2	$107M	Sell	1,321,266 -65,275	-5%	-$5.34M	0.56%	36
2021 Q1	$109M	Sell	1,386,541 -89,586	-6%	-$7.02M	0.59%	33
2020 Q4	$126M	Sell	1,476,127 -31,708	-2%	-$2.62M	0.69%	27
2020 Q3	$116M	Sell	1,507,835 -7,822	-0.5%	-$596K	0.7%	26
2020 Q2	$111M	Buy	1,515,657 +381,833	+34%	+$27.1M	0.68%	30
2020 Q1	$78.1M	Hold	1,133,824	–	–	0.36%	72
2019 Q4	$78.1M	Sell	1,133,824 -38,006	-3%	-$2.59M	0.36%	72
2019 Q3	$86.1K	Buy	1,171,830 +50,950	+5%	+$3.7M	0.39%	66
2019 Q2	$80.3K	Buy	1,120,880 +4,710	+0.4%	+$334K	0.35%	67
2019 Q1	$76.5K	Buy	1,116,170 +15,950	+1%	+$1.03M	0.35%	72
2018 Q4	$65.5K	Sell	1,100,220 -22,211	-2%	-$1.39M	0.32%	79
2018 Q3	$75.1M	Buy	1,122,431 +13,358	+1%	+$890K	0.3%	76
2018 Q2	$71.9M	Buy	1,109,073 +160,051	+17%	+$10.5M	0.32%	71
2018 Q1	$71.6M	Hold	949,022	–	–	0.3%	79
2017 Q4	$71.6M	Buy	949,022 +42,977	+5%	+$3.14M	0.3%	79
2017 Q3	$66M	Buy	906,045 +131,310	+17%	+$9.46M	0.29%	85
2017 Q2	$56.7M	Hold	774,735	–	–	0.27%	95
2017 Q1	$56.7M	Buy	774,735 +18,661	+2%	+$1.31M	0.27%	95
2016 Q4	$49.5M	Sell	756,074 -22,544	-3%	-$1.55M	0.27%	97
2016 Q3	$57.7M	Sell	778,618 -13,229	-2%	-$978K	0.33%	73
2016 Q2	$58M	Sell	791,847 -17,649	-2%	-$1.26M	0.35%	68
2016 Q1	$57.2M	Sell	809,496 -7,203	-0.9%	-$479K	0.37%	60
2015 Q4	$54.4M	Sell	816,699 -8,054	-1%	-$536K	0.37%	60
2015 Q3	$52.3M	Sell	824,753 -1,215	-0.1%	-$79.4K	0.38%	61
2015 Q2	$54M	Sell	825,968 -15,483	-2%	-$1.05M	0.39%	55
2015 Q1	$58.3M	Sell	841,451 -17,876	-2%	-$1.24M	0.43%	42
2014 Q4	$59.5M	Sell	859,327 -7,598	-0.9%	-$513K	0.47%	39
2014 Q3	$56.5M	Sell	866,925 -1,867	-0.2%	-$123K	0.5%	40
2014 Q2	$59.2M	Sell	868,792 -23,053	-3%	-$1.54M	0.53%	37
2014 Q1	$57.9M	Sell	891,845 -96,965	-10%	-$6.11M	0.54%	39
2013 Q4	$64.5M	Sell	988,810 -3,234	-0.3%	-$207K	0.66%	30
2013 Q3	$58.8M	Sell	992,044 -2,999	-0.3%	-$178K	0.7%	26
2013 Q2	$57M	Buy	+995,043	New	+$59.1M	0.71%	29

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Glenmede Trust's CL Position: Q1 2026 in Review

Glenmede Trust reduced its Colgate-Palmolive (CL) stake by 7.3% in Q1 2026, selling an estimated $4.18M and leaving 595,265 shares worth $50.7M. The position accounts for 0.25% of the portfolio, ranked #75.

Glenmede Trust first reported a position in CL in Q2 2013 and has held it in 50 quarters since. The position peaked at $126M in Q4 2020. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Glenmede Trust held 595,265 shares of Colgate-Palmolive worth $50.7M as of Q1 2026.
Glenmede Trust sold 46,946 Colgate-Palmolive shares in Q1 2026, an estimated $4.18M.
Colgate-Palmolive made up 0.25% of Glenmede Trust's portfolio in Q1 2026, its #75 holding.
Glenmede Trust first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 50 quarters since.
Glenmede Trust's Colgate-Palmolive position peaked at $126M in Q4 2020.
1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.